公开(公告)号：US20210322428A1

公开(公告)日：2021-10-21

申请号：US17285161

申请日：2019-10-17

Applicant: YUHAN CORPORATION

Inventor： Seongkyu KIM ,  Deokkyu LEE ,  Soo-Won KIM ,  Jun-Mo YANG ,  Yoong-Sik PARK

IPC: A61K31/5377 ,  A61K9/00 ,  A61K9/20

Abstract: The present disclosure provides a pharmaceutical composition for oral administration comprising: N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pirimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide (Lazertinib) or its pharmaceutically acceptable salt as an active ingredient; and a combination of microcrystalline cellulose and mannitol as a diluent.